propranolol has been researched along with puromycin in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ang, CW; Avery, VM; Blaskovich, MAT; Butler, MS; Cooper, MA; Debnath, A; Hahn, HJ; Jarrad, AM; Jones, AJ; Karoli, T; Pelingon, R; Sykes, ML; Tan, L; West, NP; Woods, K | 1 |
Etzkorn, J; Gray, J; Hopkins, P; Ingbar, SH; Segal, J | 1 |
Brunswick, DJ; Church, AC; Flexner, JB; Flexner, LB; Rainbow, TC | 1 |
Church, AC; Flexner, JB; Flexner, LB; Rainbow, TC | 2 |
Deguchi, T | 1 |
Fain, JN; Moskowitz, J | 1 |
Ingbar, SH; Segal, J | 1 |
13 other study(ies) available for propranolol and puromycin
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.
Topics: Animals; Antiparasitic Agents; Antitubercular Agents; Caco-2 Cells; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Entamoeba histolytica; Giardia lamblia; Humans; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Nitroimidazoles; Structure-Activity Relationship | 2018 |
Beta-adrenergic potentiation of the increased in vitro accumulation of cycloleucine by rat thymocytes induced by triiodothyronine.
Topics: Adrenergic beta-Agonists; Amino Acids; Animals; Cell Survival; Cycloleucine; Epinephrine; Female; Isoproterenol; Phentolamine; Practolol; Propranolol; Puromycin; Rats; T-Lymphocytes; Terbutaline; Triiodothyronine | 1979 |
Blockade of beta 1- but not of beta 2-adrenergic receptors replicates propranolol's suppression of the cerebral spread of an engram in mice.
Topics: Adrenergic beta-Antagonists; Amnesia; Animals; Avoidance Learning; Betaxolol; Brain; Cerebellum; Hippocampus; Memory; Mice; Propanolamines; Propranolol; Puromycin; Receptors, Adrenergic, beta; Time Factors | 1985 |
Blockade of peripheral beta-adrenergic receptors fails to suppress the cerebral spread of an engram in mice.
Topics: Animals; Brain; Female; Hippocampus; Limbic System; Male; Memory; Mice; Propranolol; Puromycin; Receptors, Adrenergic, beta | 1985 |
Role of the beta adrenergic receptor in the elevation of adenosine cyclic 3',5'-monophosphate and induction of serotonin N-acetyltransferase in rat pineal glands.
Topics: Acetyltransferases; Adrenergic beta-Antagonists; Animals; Carbon Isotopes; Cyclic AMP; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Induction; Isoproterenol; Male; Pineal Gland; Propranolol; Puromycin; Rats; Receptors, Adrenergic; Serotonin; Time Factors | 1973 |
Stimulation by growth hormone and dexamethasone of labeled cyclic adenosine 3',5'-monophosphate accumulation by white fat cells.
Topics: Adenine; Adenine Nucleotides; Adipose Tissue; Animals; Cyclic AMP; Cycloheximide; Depression, Chemical; Dexamethasone; Epinephrine; Ergotamine; Fatty Acids, Nonesterified; Female; Glucosyltransferases; Glycerol; Growth Hormone; Lipid Metabolism; Ovary; Propranolol; Protein Biosynthesis; Puromycin; Rats; Stimulation, Chemical; Theophylline; Time Factors; Tritium; Uterus | 1970 |
The effect of the beta-adrenergic receptor antagonist, propranolol, on the cerebral spread of a memory trace in mice.
Topics: Animals; Autoradiography; Diencephalon; Dihydroalprenolol; Female; Injections, Intraventricular; Male; Memory; Mice; Pindolol; Propranolol; Puromycin; Receptors, Adrenergic, beta; Stereoisomerism; Telencephalon | 1984 |
Direct and synergistic interactions of 3,5,3'-triiodothyronine and the adrenergic system in stimulating sugar transport by rat thymocytes.
Topics: Alprenolol; Animals; Biological Transport; Carbohydrate Metabolism; Catecholamines; Deoxyglucose; Drug Synergism; Epinephrine; Female; In Vitro Techniques; Isoproterenol; Methylglucosides; Oxidation-Reduction; Phentolamine; Phenylephrine; Propranolol; Puromycin; Rats; Thymus Gland; Triiodothyronine | 1980 |